PharmaBoardroom

Cyril Titeux – Senior VP Mid-sized Markets EMEA &…

Janssen’s Cyril Titeux highlights the commonalities and challenges within his 31-country portfolio, his hopes and expectations for the evolution of…

Localization: Japan

The key facts about localization in Japan. Prepared in association with Nishimura & Asahi, a leading law firm in Japan, this is an extract…

Antonella Santuccione Chadha – CEO pro-bono, Women’s…

Antonella Santuccione Chadha*, Head of Stakeholder Engagement for Alzheimer’s disease at Biogen and co-founder and CEO of the Women’s Brain…

Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for…

The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical company successfully listed on…

Swiss Pharma: Staying the Course

This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive up-to-date country report on the Swiss…

Japan PMDA New Drug Approvals 2020

Following on from our recent compilations of 2020 new drug approvals in the USA, China, and Switzerland, see below for the Japanese PMDA's new drug…

China: AstraZeneca/Junshi anti-PD-1 Tie-Up; New UK Biologics Plan…

The latest from Chinese pharma, including a new deal between AstraZeneca and Junshi Biosciences; Innoforce and dMed’s R&D collab; and investment…

MEA: Pfizer’s Saudi Transformation; Urgent Call for Arab Import…

The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi operations; why India is calling for…

The Long Read / Norway: Unlocking Potential

Equality has long been a deeply held ideal in Norway, where the concept of allemannsretten – the legal right to roam – permeates all aspects of…

Top 20 Companies for Access to Medicine 2021

The Top 20 companies on the 2021 Access to Medicines Index ranked on governance of access, research and development, and product delivery indices.…

Pharma Country Managers: The COVID Generation

While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive, working around the clock to ensure…

JP Morgan 2021 Virtual Healthcare Conference: A Course Correction…

David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare Conference 2021 that was held in a virtual format, noting potential changes in…

Tagged with J